Cardiovascular Ultrasound Market Size to Hit USD 4.67 Bn by 2032

The global cardiovascular ultrasound market size was valued at USD 2.65 billion in 2023 and is projected to surpass around USD 4.67 billion by 2032 with a CAGR of 6.5% from 2023 to 2032.

Key Points

  • North America led the global market with the highest market share of 31% in 2022.
  • Asia Pacific region is estimated to expand the fastest CAGR between 2023 and 2032.
  • By Type, the transthoracic echocardiography segment has held the largest market share in 2022.
  • By Technology, the doppler segment captured the biggest revenue share in 2022.
  • By Display, the black and white (B/W) segment is estimated to hold the highest market share of 89% in 2022.

Cardiovascular Ultrasound Market Size 2023 To 2032

The essential issue for the improvement of the cardiovascular ultrasound market consolidates – the rising event of cardiovascular afflictions (CVDs), climb in mechanical types of progress, and advantages of echocardiography over prominent heart logical procedures.

Cardiovascular disorders (CVD) remain a huge justification for grimness and mortality in the world and are transforming into an obviously critical justification for death in non-modern countries. As per the 2020 updates of the World Health Organization, ischemic coronary ailment, obligated for 16% of the world’s finished passing.

Get the Free Sample Copy of Report

Regional Snapshot

North America held the greatest pay part of more than 31% in 2021 owing to the better structure in clinical consideration workplaces and the high gathering of CVUS in preventive drug. In the U.S., the portions for Medicare are chosen various components including relative worth units, change factors, and geographic practice cost records. The Medicare goes with new rules, which pick the reimbursement procedure. The consistent reimbursement system and managerial design should help with prompting the market improvement around here over the guess period.

Regardless, Asia Pacific should be the speediest creating commonplace market at a CAGR of more than 7% over the gauge period. This improvement can be credited to the rising regularity of progressing conditions in the area.

Report Highlights

  • In view of type, the overall market has been divided into transthoracic echocardiography, transesophageal echocardiography, fetal echocardiography, and others. The transthoracic echocardiography segment drove the overall market in 2021.
  • Considering advancement, the market is partitioned into 2D, 3D/4D, and Doppler ultrasound systems. Doppler is the most preferred system as they give sharp pictures in a more restricted time and the piece addressed the best pay part of over 47% in 2021.
  • 2D ultrasound imaging is generally called B-mode echography or sonography. It shows a 2D aide of B-mode data and is at this point the most generally perceived sort of heart ultrasound imaging used all over the planet. It uses various transducers.

Scope of Cardiovascular Ultrasound Market

Report Coverage Details
Growth Rate from 2023 to 2032 CAGR of 6.5%
Market Size in 2023 USD 2.65 Billion
Market Size by 2032 USD 4.67 Billion
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered Type, Technology, Display, End-use, Geography
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Cardiovascular Ultrasound Market Dynamics


The main considerations for the development of the cardiovascular ultrasound framework market incorporate – the rising rate of cardiovascular sicknesses (CVDs), ascend in mechanical headways, and benefits of echocardiography over obtrusive heart demonstrative methodology.

Cardiovascular sicknesses (CVD) stay a significant reason for horribleness and mortality in the created world and are turning into an undeniably significant reason for death in emerging nations. According to the 2020 updates of the World Health Organization, ischemic coronary illness, liable for 16% of the world’s complete passings. Beginning around 2000, the biggest expansion in passings has been for ischemic coronary illness, ascending by multiple million to 8.9 million passings in 2019. Subsequently, the expansion in the quantity of cardiovascular sicknesses has expanded the interest for the cardiovascular ultrasound framework for determination.


The COVID-19 significantly affects the cardiovascular imaging framework in 2020. The component adversely affecting the concentrated-on market is the decrease in the analysis of cardiovascular sicknesses because of medical services assets being saved for COVID-19 patients. In any case, patients with hidden coronary illness are at higher gamble of extreme disease for COVID-19.


The gamble of tainting and nosocomial spreading related with the use of the standard analytic apparatuses, for example, stethoscope and radiology imaging frameworks in the administration of COVID – 19 added to the rising interest for pocket-sized cardiovascular ultrasound frameworks changing the elements of these market spaces.


adoption of very good quality cardiovascular ultrasound framework among medical services suppliers is genuinely restricted attributable to its significant expense. The frameworks that are outfitted with new and advance advancements like 4D imaging, AI, and IoT are each pricier and subsequently exorbitant for little clinics and symptomatic focuses particularly in emerging nations.

Premium machines cost between US$ 120,000 to US$ 130,000 and legislatures of arising economies can’t give adequate award to buy such costly hardware. This has restricted the deals of heart ultrasound frameworks in districts like Asia Pacific and Latin America. Absence of mindfulness among patients in regards to heart ultrasound frameworks alongside rigid guidelines will adversely influencing the market development over the gauge period. The Food and Drugs Administration (FDA) has characterized severe guidelines to moderate any hurtful aftereffects that could happen to the human body. These elements alongside absence of gifted works and master administrators will additionally control the market development over the gauge period.

Read also: Healthcare BPO Market Size to Surpass USD 864.02 Bn By 2032

Key Market Developments

  • In October 2020, GE Healthcare got the FDA leeway for Vivid Ultra Edition, an AI-controlled intended to abbreviate symptomatic test time and further develop estimation consistency.
  • In August 2020, Philips sent off its new Affiniti CVx and 7.0 for EPIQ CVx cardiovascular ultrasound arrangements, which incorporate upgrades to improve trust in determination and systems and further develop the client experience.
  • In October 2020, Royal Philips sent off Ultrasound 3300 in India. The item can be utilized for a large number of utilizations including OB/GYN, cardiovascular imaging, and general imaging.
  • In 2015, GE Healthcare marked a notice of understanding with the Oregon Health and Science University (U.S.) to embrace cooperative R&D concentrates on in the field of cardiovascular imaging and treatment as well as in large information research
  • In 2015, GE Healthcare sent off another 4D heart ultrasound programming — cSound — for three new ultrasound frameworks, to be specific, VividS70, VividE90, and VividE95 in the U.S. what’s more, a few nations in Europe, Asia, and Latin America.

The key market players are constantly engaged in various developmental strategies like partnership, collaborations, new product launches, and acquisitions to strengthen their market position and gain market share.

Cardiovascular Ultrasound Market Companies

  • GE Healthcare
  • Koninklijke Philips
  • Siemens Healthineers AG
  • Hitachi Medical Corp.
  • Samsung Medison Co. Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Mindray)
  • Chison Wuxi Xiangsheng Medical Technology Co., Ltd.
  • Fujifilm Sonosite, Inc.

Segments Covered in the Report

By Type

  • Transthoracic Echocardiography
  • Transoesophageal Echocardiography
  • Foetal Echocardiography
  • Others

By Technology 

  • 2D
  • 3D/4D
  • Doppler
  • Others

By Display 

  • Black & White (B/W)
  • Color

By End-use

  • Hospital
  • Diagnostic Centers
  • Ambulatory Care Centers
  • Others

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333







Leave a Reply

Your email address will not be published. Required fields are marked *